yes i am aware. biggest frustration of LGND reg. shares have been just that... mkt seems to be asleep on LGND (vs GILD which is getting the attention, rightfully so). LGND is so undervalued..
GILD will prob be > $100 once CV drug is 'approved' - how can they NOT approve imo.... for many reasons.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.